Strategic Communication to Maximize the Value of Advanced Biopharmaceuticals — Supporting Global Expansion with Expert Reporting and Multilingual Capabilities

Stella Medix Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Yoshitaka Hoshi) is strengthening its specialized content development services in the field of aesthetic medicine. In an increasingly diversified landscape, we are committed to delivering evidence-based, accurate, and neutral information to those seeking trustworthy resources.

Aesthetic treatment image showing a device being applied to a woman's face
Image: Adobe Stock

Turning Challenges into Opportunities — Creating Trustworthy Aesthetic Medicine Content

Non-surgical treatments such as hyaluronic acid fillers, botulinum toxin injections, biostimulators, lasers, radiofrequency (RF), high-intensity focused ultrasound (HIFU), and thread lifts are expanding rapidly. With the influx of new devices and products from overseas, the diversity of procedures continues to grow. Meanwhile, surgical aesthetic procedures are becoming more complex, requiring a higher level of medical expertise. Under Japan’s medical advertising guidelines, sensational or misleading expressions must be avoided, and the demand for objective, balanced information is increasing. As issues and disputes surrounding aesthetic medicine become more visible, providing reliable care and sincere services is more critical than ever. In this environment, delivering accurate information has become a responsibility of medical institutions.

Key Issues and Our Approach

  • Rapid expansion of treatment options — Each procedure requires specialized and informed content.
  • Growing body of evidence — Even in private practice, safety and efficacy must be clearly communicated.
  • Need for information accuracy — A deep understanding of specialties such as dermatology and plastic surgery is essential.
  • Gap between providers and patients — Clear and accessible explanations bridge understanding while respecting professional integrity.

Enhancing Content Quality with a Specialized Editorial Team

Led by CEO Yoshitaka Hoshi — a licensed veterinarian and veteran medical journalist — our team leverages extensive experience in content production. We offer comprehensive support including interviews, literature reviews, clinical data interpretation, and more. Our services cover clinic websites, procedure explanation materials, brochures for medical devices and products, social media posts, video scripts, and video production.

Service Highlights

  • Content based on scientifically sound primary sources
  • Compliance with advertising and information-related regulations
  • Optimization across web, print, and video formats
  • Up-to-date knowledge of academic trends and publications
  • Multilingual content production (Japanese, English, Korean, Chinese — Simplified/Traditional)

Track Record

  • Website planning and operation
  • Book and publication development
  • On-site coverage of medical conferences
  • Production of short-form videos for social media
  • White papers for manufacturers based on scientific evidence

Together, let’s create aesthetic medicine that is valued through the power of high-quality, meaningful information — especially in uncertain times.

Contact

If you are in need of professionally crafted, medically sound content, please feel free to reach out to us via the contact details below.

Stella Medix Inc.

6F Kinyō Building, 1-6-13 Kyōbashi, Chuo-ku, Tokyo 104‑0031, Japan

TEL: +81-3-3535-2015

Website: https://stellamedix.com/contact/

会社概要

株式会社ステラ・メディックスは、ヘルスケア、医療、バイオテクノロジーの最前線で情報発信をサポートします。コンテンツ制作やコンサルティングなどのプランを提供。

プラン

株式会社ステラ・メディックスは医療や健康分野、食品分野、アニマルヘルス分野の執筆・編集・審査監修を担います。クライアントのニーズに基づいてプランを創出しています

お問い合わせ

株式会社ステラ・メディックスは医療や健康分野、食品分野、アニマルヘルス分野の執筆・編集・審査監修を担います。お問い合わせはこちら画像のリンクよりお願いします。